NEU 3.32% $20.52 neuren pharmaceuticals limited

Ann: Trading Halt, page-155

  1. 387 Posts.
    lightbulb Created with Sketch. 15
    Your post was defending a poster who was criticised for asking a dumb question. Your example about NVIDIA shareholders is irrelevant. Someone who buys this share probably should be aware of the 3 current trials they’re running? You know as the major catalysts for them making money from what they’ve bought?
    The original post asked what PMS was. The genetic disorder that the company is developing a drug for. The reason for the trading halt.

    So yeah. To post on a thread about a trading halt, for a stock you own asking what the disorder it is trying to treat is…pretty dumb. And it’s not like they’re currently running 100s of trials.


 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.